Morning Overview on MSN
The FDA approved a lower-dose contrast agent to cut patients’ exposure during MRI scans
Patients who need repeated MRI scans with contrast dye could soon receive a fraction of the gadolinium they currently get. The FDA approved gadoquatrane, a new gadolinium-based contrast agent designed ...
Morning Overview on MSN
The FDA just added a kidney-damage warning to a popular over-the-counter diet pill
Anyone who has picked up a box of alli from a drugstore shelf without a prescription now faces a new risk disclosure. The FDA ...
For most of modern economic history, building a serious business meant building a team. You needed people to cover the gaps — ...
Dangote Petroleum Refinery targets a $40-50 billion IPO valuation as Nigerians rush to open brokerage accounts. Pre-IPO ...
Inside a hydro rewind where megawatts mattered less than reliability. GE Vernova's Moccasin project protected water for 2.7 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results